Context Therapeutics Inc. (CNTX)

Context Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	94.43	14.45	35.5	49.64	0.29
Cash & Short-Term Investments	94.43	14.45	35.5	49.64	0.29
Cash Growth	553.50%	-59.29%	-28.48%	16976.13%	28.27%
Prepaid Expenses	3.47	1.6	2.36	1.62	0.01
Total Current Assets	97.9	16.05	37.85	51.26	0.3
Property, Plant & Equipment	0.23	0.02	0.08	-	-
Long-Term Deferred Charges	-	-	-	-	0.12
Other Long-Term Assets	-	-	0.03	0.05	0.05
Total Assets	98.13	16.06	37.97	51.31	0.47
Accounts Payable	1.45	2.38	0.94	1.83	2.71
Accrued Expenses	1.14	1.8	2.13	1.12	0.96
Short-Term Debt	-	-	-	-	5.83
Current Portion of Long-Term Debt	-	-	-	-	0.06
Current Portion of Leases	0.11	-	0.06	-	-
Other Current Liabilities	0.05	0.01	0.08	0.09	-
Total Current Liabilities	2.75	4.19	3.21	3.03	9.55
Long-Term Debt	-	-	-	-	0.07
Long-Term Leases	0.11	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.03
Total Liabilities	2.86	4.19	3.21	3.03	9.65
Common Stock	0.09	0.02	0.02	0.02	0
Additional Paid-In Capital	189.96	79.91	78.83	77.51	1.88
Retained Earnings	-94.78	-68.05	-44.09	-29.25	-18.8
Total Common Equity	95.27	11.87	34.76	48.27	-16.92
Shareholders' Equity	95.27	11.87	34.76	48.27	-9.18
Total Liabilities & Equity	98.13	16.06	37.97	51.31	0.47
Total Debt	0.22	-	0.06	-	5.95
Net Cash (Debt)	94.21	14.45	35.44	49.64	-5.66
Net Cash Growth	551.98%	-59.23%	-28.59%	-	-
Net Cash Per Share	1.61	0.91	2.22	17.52	-2.76
Filing Date Shares Outstanding	89.7	15.97	15.97	15.97	0.33
Total Common Shares Outstanding	89.7	15.97	15.97	15.97	0.33
Working Capital	95.15	11.86	34.65	48.22	-9.25
Book Value Per Share	1.06	0.74	2.18	3.02	-51.00
Tangible Book Value	95.27	11.87	34.76	48.27	-16.92
Tangible Book Value Per Share	1.06	0.74	2.18	3.02	-51.00

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q